Literature DB >> 19870969

SOME CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA.

J E Smadel1, G I Lavin, R J Dubos.   

Abstract

Treatment of elementary bodies of vaccinia with dilute solutions of sodium hydroxide resulted in the extraction of certain soluble materials accounting for half of the dry weight of the virus. Elementary bodies contained about 0.4 per cent inorganic phosphorus, practically all of which occurred in the form of a nucleoprotein containing thymus nucleic acid. In addition, a substance was recovered that reacted with S antibodies. From past experience one is led to believe that S antigen, as ordinarily encountered, is a protein which is not in combination with nucleic acid.

Entities:  

Year:  1940        PMID: 19870969      PMCID: PMC2134988          DOI: 10.1084/jem.71.3.373

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Rheumatic Fever following Erysipelas.

Authors:  B Schlesinger
Journal:  Proc R Soc Med       Date:  1934-01

2.  EFFECT OF INTENSE SONIC VIBRATIONS ON ELEMENTARY BODIES OF VACCINIA.

Authors:  T M Rivers; J E Smadel; L A Chambers
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

3.  IMMUNOLOGICAL STUDIES OF A HEAT-STABLE SUBSTANCE ISOLATED FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker
Journal:  J Exp Med       Date:  1938-02-28       Impact factor: 14.307

4.  STUDIES ON THE SOLUBLE PRECIPITABLE SUBSTANCES OF VACCINIA : I. THE DISSOCIATION IN VITRO OF SOLUBLE PRECIPITABLE SUBSTANCES FROM ELEMENTARY BODIES OF VACCINIA.

Authors:  J Craigie; F O Wishart
Journal:  J Exp Med       Date:  1936-10-31       Impact factor: 14.307

5.  IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : VI. ISOLATION OF A HEAT-STABLE, SEROLOGICALLY ACTIVE SUBSTANCE FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker; T M Rivers
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

6.  ESTIMATION OF THE PURITY OF PREPARATIONS OF ELEMENTARY BODIES OF VACCINIA.

Authors:  J E Smadel; T M Rivers; E G Pickels
Journal:  J Exp Med       Date:  1939-09-30       Impact factor: 14.307

7.  STUDIES ON THE SOLUBLE PRECIPITABLE SUBSTANCES OF VACCINIA : II. THE SOLUBLE PRECIPITABLE SUBSTANCES OF DERMAL VACCINE.

Authors:  J Craigie; F O Wishart
Journal:  J Exp Med       Date:  1936-10-31       Impact factor: 14.307

8.  IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : II. CHEMICAL ANALYSIS OF ELEMENTARY BODIES OF VACCINIA.

Authors:  T P Hughes; R F Parker; T M Rivers
Journal:  J Exp Med       Date:  1935-08-31       Impact factor: 14.307

9.  PROTEIN FRACTIONS OF A SCARLATINAL STRAIN OF STREPTOCOCCUS HEMOLYTICUS.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1931-09-30       Impact factor: 14.307

10.  ELEMENTARY BODIES OF VACCINIA FROM INFECTED CHORIO-ALLANTOIC MEMBRANES OF DEVELOPING CHICK EMBRYOS.

Authors:  J E Smadel; M J Wall
Journal:  J Exp Med       Date:  1937-08-31       Impact factor: 14.307

View more
  5 in total

1.  THE LS-ANTIGEN OF VACCINIA : I. INHIBITION OF L- AND S-ANTIBODIES BY SUBSTANCES IN TREATED VACCINE DERMAL FILTRATE.

Authors:  J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1942-01-31       Impact factor: 14.307

2.  MORPHOLOGICAL STRUCTURE OF THE VIRUS OF VACCINIA.

Authors:  R H Green; T F Anderson; J E Smadel
Journal:  J Exp Med       Date:  1942-06-01       Impact factor: 14.307

3.  ELECTROPHORETIC STUDIES ON ELEMENTARY BODIES OF VACCINIA.

Authors:  T Shedlovsky; J E Smadel
Journal:  J Exp Med       Date:  1940-10-31       Impact factor: 14.307

4.  CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : II. PROPERTIES OF NUCLEIC ACID OBTAINED FROM VACCINE VIRUS.

Authors:  C L Hoagland; G I Lavin; J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1940-07-31       Impact factor: 14.307

5.  CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : I. CERTAIN BASIC ANALYSES AND OBSERVATIONS ON LIPID COMPONENTS OF THE VIRUS.

Authors:  C L Hoagland; J E Smadel; T M Rivers
Journal:  J Exp Med       Date:  1940-05-31       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.